Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Molly Hemenway

Concepts (82)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glioma
4
2023
285
1.010
Why?
Brain Neoplasms
6
2020
966
0.480
Why?
Radiation Injuries
3
2020
128
0.400
Why?
Neurofibroma, Plexiform
1
2023
5
0.220
Why?
Neurofibromatosis 1
1
2023
36
0.210
Why?
Mitogen-Activated Protein Kinase Kinases
1
2023
113
0.200
Why?
Pyrimidinones
1
2023
88
0.200
Why?
Ependymoma
2
2014
152
0.190
Why?
Pyridones
1
2023
122
0.190
Why?
Vinblastine
2
2020
63
0.180
Why?
Weight Gain
1
2023
453
0.170
Why?
Child
12
2023
18401
0.160
Why?
Chemoradiotherapy
1
2020
187
0.160
Why?
Incidence
2
2023
2314
0.160
Why?
Central Nervous System Neoplasms
1
2020
125
0.160
Why?
Neoplasm Recurrence, Local
2
2014
850
0.150
Why?
Craniospinal Irradiation
1
2018
4
0.150
Why?
Child, Preschool
6
2023
9114
0.150
Why?
Protein Kinase Inhibitors
1
2023
784
0.140
Why?
Cytokines
2
2023
1824
0.140
Why?
Electric Stimulation Therapy
1
2017
57
0.130
Why?
Vincristine
1
2016
98
0.130
Why?
Bilirubin
1
2016
88
0.130
Why?
Infant
4
2023
7943
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2023
1356
0.130
Why?
Pons
1
2015
30
0.130
Why?
Cataract
1
2018
184
0.120
Why?
Chemical and Drug Induced Liver Injury
1
2016
125
0.120
Why?
Adolescent
8
2023
17800
0.120
Why?
Brain Stem Neoplasms
1
2015
84
0.120
Why?
Retrospective Studies
5
2023
12521
0.110
Why?
Infratentorial Neoplasms
1
2013
44
0.110
Why?
Antineoplastic Agents
2
2017
1875
0.100
Why?
Young Adult
4
2023
10444
0.100
Why?
Radiosurgery
1
2014
299
0.090
Why?
Nausea
1
2009
99
0.080
Why?
Vomiting
1
2009
122
0.080
Why?
Morpholines
1
2009
102
0.080
Why?
Adult
4
2023
30375
0.070
Why?
Humans
13
2023
114045
0.070
Why?
Follow-Up Studies
3
2020
4392
0.060
Why?
Transcriptome
2
2023
723
0.060
Why?
RNA, Small Nuclear
1
2023
31
0.050
Why?
Magnetic Resonance Imaging
1
2013
3039
0.050
Why?
Brain
1
2013
2355
0.050
Why?
Ligands
1
2023
556
0.050
Why?
Proto-Oncogene Proteins B-raf
1
2023
191
0.050
Why?
Tumor Microenvironment
1
2023
428
0.040
Why?
Carboplatin
1
2020
135
0.040
Why?
Prognosis
2
2020
3315
0.040
Why?
Neoplasm Grading
1
2020
241
0.040
Why?
Female
7
2020
59324
0.040
Why?
RNA
1
2023
806
0.040
Why?
Male
6
2020
55396
0.030
Why?
Disease Progression
1
2023
2371
0.030
Why?
Radiotherapy
1
2017
175
0.030
Why?
Survival Rate
1
2020
1638
0.030
Why?
Treatment Outcome
3
2017
9049
0.030
Why?
Antineoplastic Agents, Phytogenic
1
2016
181
0.030
Why?
Combined Modality Therapy
1
2017
1117
0.030
Why?
Microarray Analysis
1
2013
118
0.030
Why?
Necrosis
1
2013
209
0.030
Why?
Kaplan-Meier Estimate
1
2014
813
0.020
Why?
Radiography
1
2013
803
0.020
Why?
Infant, Newborn
1
2020
5038
0.020
Why?
Immunohistochemistry
1
2013
1624
0.020
Why?
Ondansetron
1
2009
8
0.020
Why?
Metabolic Clearance Rate
1
2009
102
0.020
Why?
Placebos
1
2009
197
0.020
Why?
Neutropenia
1
2009
123
0.020
Why?
Area Under Curve
1
2009
273
0.020
Why?
Mice
1
2023
14843
0.020
Why?
Dexamethasone
1
2009
316
0.020
Why?
Polymorphism, Single Nucleotide
1
2013
1880
0.020
Why?
Drug-Related Side Effects and Adverse Reactions
1
2009
239
0.020
Why?
Age Factors
1
2013
2885
0.020
Why?
Double-Blind Method
1
2009
1656
0.010
Why?
Cohort Studies
1
2013
4883
0.010
Why?
Aged, 80 and over
1
2013
6306
0.010
Why?
Animals
1
2023
31565
0.010
Why?
Aged
1
2013
18969
0.010
Why?
Middle Aged
1
2013
26605
0.010
Why?
Hemenway's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)